Home › Free Stock Grades › AGEN
Agenus Inc. (AGEN) Stock Grade
AGEN · Healthcare
A
Market Cap
$392.7M
P/E Ratio
811.9
Revenue Growth (YoY)
+10.4%
Net Margin
0.1%
Return on Equity
—
Dividend Yield
None
About Agenus Inc.'s fundamentals
Agenus Inc. is a biotechnology company with a market capitalization of $392.7 million that has achieved 10.4% year-over-year revenue growth. However, the company operates with an extremely thin net margin of just 0.1%, indicating that profitability remains minimal despite revenue expansion. The company's P/E ratio of 811.9 reflects minimal earnings, and it does not currently pay a dividend to shareholders.